Gene Delivery
Partnership
Approach
About
News
Blog
Menu
Close
Deep diversification of an AAV capsid protein by machine learning
Publications
February 11, 2021
Nature Biotechnology
TOC LINK
TOC LINK
Publications
Published
February 11, 2021
More like this
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Announcements
Dyno Therapeutics
May 14, 2025
343 Arsenal St
Watertown, MA 02472
© Dyno 2024
Privacy Policy
Terms + Conditions